Brazilian Journal of Otorhinolaryngology

Papers
(The H4-Index of Brazilian Journal of Otorhinolaryngology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Olfactory and taste disorders in COVID-19: a systematic review54
Incomplete and late recovery of sudden olfactory dysfunction in COVID-1954
Sensorineural hearing loss in a case of congenital Zika virus38
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma26
Human papillomavirus infection and oral squamous cell carcinoma - a systematic review25
Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review21
An update on COVID-19 for the otorhinolaryngologist – a Brazilian Association of Otolaryngology and Cervicofacial Surgery (ABORL-CCF) Position Statement20
Factors influencing the quality of life of children with cochlear implants20
Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement19
The close relationship between sudden loss of smell and COVID-1918
Diagnosing acquired syphilis through oral lesions: the 12 year experience of an Oral Medicine Center18
Gadolinium-enhanced MRI reveals dynamic development of endolymphatic hydrops in Ménière's disease18
Complications of tracheostomy in children: a systematic review17
Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial16
Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study16
Effects of maxillary expansion on hearing and voice function in non-cleft lip palate and cleft lip palate patients with transverse maxillary deficiency: a multicentric randomized controlled trial16
0.054795980453491